Abhishek Maiti

27PUBLICATIONS
101CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTime-series analysisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 17, 2026
Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

|Jun 27, 2026
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.

|Jun 22, 2026
Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

|Feb 04, 2026
Global Epidemiologic Trends of Early-Onset Cancers From 1990 to 2021 and Projection to 2040.

Rupayan Kundu, Ankush Mukhopadhyay, Niladri Kal

|Jun 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.

Courtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi

|Apr 08, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.

Naval Daver, Jayastu Senapati, Hagop M Kantarjian

Pageof 5

Frequent Collaborators

19 joint publications

Naval G Daver

17 joint publications

Tapan M Kadia

16 joint publications

Nicholas Short

16 joint publications

Elias Jabbour